The Stable Isotope Labeled Compounds (SILCs) market is a subset of the drug discovery industry. SILCs are compounds that have been labeled with stable isotopes, such as carbon-13 or deuterium, to enable researchers to track the metabolic pathways of drugs in the body. SILCs are used in drug discovery to study the pharmacokinetics and pharmacodynamics of drug candidates, as well as to identify potential drug targets. SILCs are also used in drug metabolism studies to assess the safety and efficacy of drug candidates.
The SILCs market is expected to grow in the coming years due to the increasing demand for drug discovery and development. The increasing prevalence of chronic diseases, such as cancer and diabetes, is also driving the growth of the SILCs market.
Some of the key players in the SILCs market include Cambridge Isotope Laboratories, Inc., Isotec, Inc., Cambridge Isotope Laboratories, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isotec, Inc., Isot Show Less Read more
